Live Breaking News & Updates on Egovy

Stay informed with the latest breaking news from Egovy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Egovy and stay connected to the pulse of your community

Why 'magic pill' weight-loss drugs are far more dangerous than you think

If you type the names of the weight-loss drugs Wegovy or Ozempic into a search engine, sponsored links dominate the page. “Starts from £149 – UK regulated and approved”, says the first to pop-up on my laptop. “Free next-day UK delivery,” promises a second. You have to start scrolling to find any information that isn’t paid for, let alone trustworthy.

United-states , United-kingdom , America , Johann-hari , Max-pemberton , European-medicines-agency , Magic-pill , Fleet-street , North-america , Eight-loss-drugs , Egovy , Agic-pill

Ozempic's next move, Southwest's seating change, Big Tech's troubles

Plus, Wegovy could soon treat millions of Medicare patients

Bob-jordan , Southwest-airlines , Outhwest-airlines , Herwood , Mazon , Hange-healthcare , Emaglutide , Egovy , Irline , Bs , Ike , Nc-

Ozempic hits booze sales, Moderna likes AI, Biogen's blockbuster drug

Plus, Bernie Sanders launches an investigation into Wegovy and Ozempic prices, and Bristol-Myers Squibb prepares to lose lucrative patents

Bristol-myers-squibb , Novartis , Astrazeneca , Wall-street , Biogen , Iogen , Oderna , Penai , Ovartis , Erck , Egovy

Ozempic threatens booze, an AI glossary, tech troubles, produce pesticides

Plus, Trump gets a Trump Media payday, and Southwest Airlines may drop its open seating policy

Consumer-reports , Bob-jordan , Outhwest-airlines , Usiness , Inance , Mazon , Rtificial-intelligence , Esla , Emaglutide , Ime-person-of-the-year , Arry-ellison

Bernie Sanders Is Taking on Ozempic's 'Astronomically High' Price Tag

Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications. On Wednesday, Sanders’ office announced that the senator is launching an investigation into Novo Nordisk over the “astronomically high” list prices of their drugs Wegovy and Ozempic. Both drugs can cost around $1,000 a month or more without insurance coverage.

Germany , United-states , Americans , Eli-lilly , Instagram , Senate-health , Facebook , Twitter , United-states-congress , Novo-nordisk , Senator-bernie-sanders , Big-pharma

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances?

The animal studies are promising but early research in humans show mixed results. Here’s what we know so far.

Australia , Australians , Addiction , Lcohol , Lcohol-use , Rug-use , Lp-1 , Ealth , Ealth-analysis , Zempic , Zempic-series

3.6 million Medicare enrollees may now be eligible for Wegovy coverage

About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare nearly $3 billion a year and contribute to higher Part D premiums for all beneficiaries.

Juliette-cubanski , Cnn , Novo-nordisk , Program-on-medicare , Drug-administration , Health-aetna , Medicare-policy , Medicare , Ligible-beneficiaries , Ff , Iabetes-drugs , Egovy

1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban

An estimated 3.6 million Medicare beneficiaries could potentially access Wegovy now that the Food and Drug Administration (FDA) approved the drug for reducing the risk of incidents related to cardiovascular disease. A KFF analysis found that among the 13.7 million people on Medicare diagnosed with obesity, 3.6 million, or roughly 1 in 4, of these…

Drug-administration , Novo-nordisk , Medicare-modernization-act , Reduce-obesity-act , Cardiovascular-disease , Edicare , Ood-and-drug-administration , Besity , Edicare-modernization-act , Egovy , Ff

Wegovy could treat millions of Medicare patients, study says

The popular weight loss drug could be covered for at least 3.6 million people under new Medicare rules, KFF says

United-states , Americans , Eli-lilly-zepbound , Eli-lilly , Medicaid-services , Drug-administration , Novo-nordisk , Kaiser-family-foundation , Centers-for-medicare , Medicare , Egovy , He-centers-for-medicare-and-medicaid-services

Nearly 4 million Medicare patients with heart disease may be eligible for Wegovy coverage

Discover how the FDA's approval of Wegovy for reducing heart attack and stroke risk in overweight and obese individuals could open Medicare coverage

Medicare , Egovy , Da , Eart-attack , Trokes , Besity , Ardiovascular-disease , Lp-1s , Ardiology , Eart-treatment ,